Bone complications of cancer<unk>  is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer, as well as for treating osteoporosis. It can also be used to treat hypercalcemia of malignancy and can be helpful for treating pain from bone metastases. It can be given at home rather than in hospital. Such use has shown safety and quality-of-life benefits in people with breast cancer and bone metastases. Osteoporosis<unk> , in brand name products Aclasta and Reclast among others, may be given as a 5 mg infusion once per year for treatment of osteoporosis in men and post-menopausal women at increased risk of fracture. In 2007, the U.S. Food and Drug Administration (FDA) also approved it for the treatment of postmenopausal osteoporosis. Other<unk>  may be used for treatment of osteogenesis imperfecta. A single 5 mg dose of<unk>  is used for the treatment of Paget's disease.
Zoledronic acid
Medronic acid
Risedronic acid
Alendronic acid
Pamidronic acid
Denosumab
Etidronic acid
Ibandronic acid